Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04497220 · ClinicalTrials.gov registry record · NA

Poke and a Placebo

A NA study of Anesthesia, sponsored by University of Minnesota.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT04497220: Recruiting NA study of Anesthesia, sponsored by University of Minnesota.

NCT04497220 is a NA study of Anesthesia that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 30 participants, below the 109,410-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04497220, a NA study of Anesthesia, is actively recruiting participants, sponsored by University of Minnesota.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

To discover if a positive description of the procedure for an epidural can reduce the overall pain score associated with the procedure.

Primary Outcome

Maximum pain score will be measured using a single 11-point Numeric Rating Scale 0-10, where 0 is no pain and 10 is maximum imaginable pain.

Conditions Studied

Interventions

  • BEHAVIORAL Negative Connotation Langauge
  • BEHAVIORAL Positive Connotation Language

Study Locations (1)

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2021-07-12
Est. Completion 2026-12-31
Phase NA
University of Minnesota

966 total trials

What NCT04497220 shows while recruiting

NCT04497220 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 109,410-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Anesthesia appearing as the primary indexed condition, and to 2 interventions - of which Negative Connotation Langauge is the first listed.

NCT04497220 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT04497220 about?

NCT04497220 is a clinical study titled "Poke and a Placebo". To discover if a positive description of the procedure for an epidural can reduce the overall pain score associated with the procedure.

What is the current status of trial NCT04497220?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2021-07-12. Estimated completion is 2026-12-31.

What conditions does trial NCT04497220 study?

This clinical trial studies the following conditions: Anesthesia.

What interventions are being tested in trial NCT04497220?

The interventions under investigation include: Negative Connotation Langauge (BEHAVIORAL), Positive Connotation Language (BEHAVIORAL).

Who is sponsoring clinical trial NCT04497220?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04497220 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anesthesia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04497220's enrollment target sits among peer trials

30 45th of 57 higher than 11 of 57 other Anesthesia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anesthesia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04497220, the US trial registry maintained by the National Library of Medicine. NCT04497220 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.